Drawing based on the label description. No photo yet.
725 pill
Pill with imprint 725 is yellow, oval, 12 mm and has been identified as Methylphenidate Hydrochloride 18 mg. It is supplied by Actavis Pharma, Inc.
Controlled substance: Schedule II
Methylphenidate Hydrochloride 18 mg
- Imprint
- 725
- Strength
- 18 mg
- Color
- Yellow
- Shape
- Oval
- Size
- 12 mm
- Score
- No score line
- Form
- Tablet, film coated, extended release
- Manufacturer
- Actavis Pharma, Inc
- NDC
- 62037-725, 62037-725-01
Is this your pill? Check every detail
- The imprint reads exactly 725, on the same sides.
- It is yellow, oval, 12 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Methylphenidate Hydrochloride
Inactive: Silicon Dioxide, Fumaric Acid, Hypromellose 2208 (100 Mpa.s), Hypromellose 2910 (5 Mpa.s), Hypromellose 2910 (15 Mpa.s), Lactose Monohydrate, Magnesium Stearate, Methacrylic Acid - Methyl Methacrylate Copolymer (1:1), Methacrylic Acid - Methyl Methacrylate Copolymer (1:2), Talc, Titanium Dioxide, Triethyl Citrate, Ferric Oxide Red, Ferric Oxide Yellow, Polyethylene Glycol 3350, Polyvinyl Alcohol, Unspecified, Ammonia, Ferrosoferric Oxide, Propylene Glycol, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
Other Methylphenidate Hydrochloride pills
-
10 M
Methylphenidate Hydrochloride 10 mg
White, round, 7 mm
Schedule II
- 10 MG M 1810 Methylphenidate Hydrochloride 10 mg Green & white, capsule, 14 mm Schedule II
- 1423 M Methylphenidate Hydrochloride 10 mg White, round, 6 mm Schedule II
- 1451 M Methylphenidate Hydrochloride 20 mg White, round, 7 mm Schedule II
- 18 Methylphenidate Hydrochloride 18 mg Yellow, round, 8 mm Schedule II
- 18 Methylphenidate Hydrochloride 18 mg Pink, round, 6 mm Schedule II
- 20 M Methylphenidate Hydrochloride 20 mg White, round, 8 mm Schedule II
- 20 MG M 1820 Methylphenidate Hydrochloride 20 mg Blue & white, capsule, 16 mm Schedule II





